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Background: Cephalotaxus spp. are known to possess anticancer potential. In this present work, for the first time
the effects of C. griffithii needle (CGN) extracts on human cancer cells were examined.
Methods: The CGN was successively extracted with petroleum ether (PE), acetone and methanol. The extracts
were tested for its effect on proliferation of cancer cells (MTT assay on HeLa, ZR751 and HepG2). Extract that
showed the maximum growth inhibitory effect was subjected for mechanism of action study. These included
apoptosis (morphological and DNA fragmentation assay), cell cycle (flow cytometry), caspase expression (Western
blot) and activity (assay kit), p53 (western blot and TP53 siRNA interference) and telomerase expression (reverse
transcriptase PCR) analysis.
Results: Among the extracts, PE extract induced maximum cytotoxicity, with highest death occurred in ZR751
cells. Since, PE extract induced cell death was highest among the CGN extracts, with maximum cancer cell death
occurred in ZR751 cells; we carried out mechanism study of PE extract induced ZR751 cell death. It was observed
that PE extract induced ZR751 cell death was associated with cell cycle arrest and apoptosis by activating both
intrinsic and extrinsic apoptotic pathways. Knock down study revealed that p53 is essential for loss of ZR751 cell
viability induced by PE extract. Further, PE extract down-regulated hTERT, hTR, and c-Myc expression. Thin layer
chromatography analysis indicated the presence of unique phytochemicals in PE extract.
Conclusion: Based on the observations, we concluded that PE extract of C. griffithii needle contains important
phyto-components with multiple cellular targets for control of breast cancer and is worthy of future studies.
Keywords: Cephalotaxus griffithii, Apoptosis, Cell cycle, Telomerase, p53Background
Mortality due to cancer is becoming unacceptably high
and is therefore a worldwide concern. Statistics indicate
that the total number of cancer deaths in 2007 was 7.6
million, of which 62% were in developing countries and
38% in developed countries [1]. By 2050, 27 million new
cases and 17.5 million cancer deaths are expected globally* Correspondence: nctalukdar@yahoo.com
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article, unless otherwise stated.[1]. Therefore, serious efforts have been made to reduce
the threat of cancer all over the globe.
Historically, natural products have served as a rich
source of lead compounds for drug development against
a wide array of biological targets, including various
forms of cancer. Search continues in rigorous footing to
discover unexplored plants and animals as potential new
sources of anticancer drugs. Since 1940, almost 75% of ap-
proved small molecules for the treatment of cancer have
been either natural products, semi-synthetic derivatives of
natural product scaffolds, or synthetic compounds in-
spired by natural products pharmacophores [2].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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scientific interest as it contains anticancer potential in-
gredients [3-6]. Homoharringtonine, an alkaloid isolated
from Cephalotaxus harringtonia was recently approved by
USFDA for the treatment of adult patient with chronic
myeloid leukemia [7]. In view of the importance of the
Cephalotaxus genus, we searched for unexplored species
within this genus to check for anticancer potential compo-
nents. Cephalotaxus griffithii Hook. f., a gymnosperm in
the family Cephalotaxaceae, is another important species
commonly known as Griffith's plum yew. It is a shrub or
small tree and found up to an altitude of 2000 m and is
distributed in North East India, western Sichuan province
in China, and Myanmar [8]. C. griffithii mostly remained
unexplored due to remoteness of location and limited ac-
cessibility of the habitat of this species. So far, only three
studies from C. griffithii have been attempted. Kamil et al.
[9] isolated and characterized six flavonoids, Phutdhawong
et al. [10] carried out chemical analysis of volatile oil from
needles of C. griffithii. Moirangthem et al. [11] analysed
the biological activity of the bark extracts of C. griffithii.
Since plant constituents are distributed in different parts
[12-14], needles of C. griffithii may also contain com-
pounds with anticancer properties. Moreover, needles can
also serve as a better source because it eliminates the risk
of destruction associated with harvest of bark. In this
study, we determined the effect of Cephalotaxus griffithii
needle (CGN) extract on human cancer cells in terms of





bromide (MTT); acridine orange (AO); ethidium bromide
(EB); propidium iodide (PI); and cell culture chemicals
were purchased from Sigma-Aldrich Chemicals Pvt. Ltd.
(Mumbai, India). Curcumin was purchased from HiMedia
Laboratories Pvt. Ltd. (Mumbai, India). Proteinase-K and
RNase were purchased from Bangalore Genei (Bangalore,
India), and the rest of the chemicals and solvents used
were of analytical grade.
Plant material
The CGNs were collected from Kangchup Hills, Manipur,
India (N24°52′10′ E093°46′12′) at an elevation of
1534.66 m above sea level. The specimen was identified by
Dr. Biseshwori Thongam, Plant Systematics and Conser-
vation Laboratory, Medicinal, Aromatic and Horticultural
Plant Resources Division, Institute of Bioresources and
Sustainable Development (IBSD), Manipur, India and by
Dr. S.K. Verma, National Bureau of Plant Genetics Re-
sources, Meghalaya, India. A voucher specimen (IBSD/C/
102) has been deposited to the IBSD herbarium.Preparation of CGN extracts
The CGNs were air dried at room temperature and pow-
dered. The powdered needles were then exhaustively ex-
tracted successively by soaking (which prevents the loss of
biological activity of some heat-sensitive ingredients) in pet-
roleum ether (PE), acetone (ACE), and methanol (MeOH)
in order to fractionate the phytochemical constituents. Fil-
tration was performed and the filtrates were concentrated
in vacuo using a vacuum rotary evaporator (EYELA, Japan)
and finally freeze dried (Thermo, Modulyod). The dried ex-
tracts were kept at 4°C until further analysis.
Test sample preparation
Solutions of the test samples for the entire study were
prepared in DMSO, except for the PE extract in which
the sample was prepared in 1, 4-dioxan.
Cell culture
The experimental cell lines were procured from the Na-
tional Centre for Cell Science (Pune, India). HeLa and
ZR751 cells were grown in DMEM (Dulbecco’s modified
Eagle’s medium) and HepG2 was grown in RPMI-1640
medium supplemented with 10% (v/v) heat-inactivated
fetal bovine serum (FBS) and 1% antibiotic antimycotic so-
lution (10,000 U/ml penicillin, 10 mg/ml streptomycin
sulfate, and 25 μg/ml amphotericin-B), and maintained at
37°C in a humidified atmosphere with 5% CO2/95% air.
MTT reduction assay
Cytotoxicity analysis was determined using the MTT
assay as reported by Mosmann [15]. Cancer cells grown
in T-25 culture flasks were harvested by trypsinization,
plated at an approximate density of 2 × 104 cells/well in
96-well culture plates, and incubated for 24 h. Next the
medium from each well was removed and the cells were
washed twice with Dulbecco’s phosphate buffered saline
(PBS). The cells were then exposed to increasing concentra-
tions of extract (5–160 μg/ml) for 24 h. After incubation,
the contents were replaced with MTT dissolved in serum-
free medium (1.2 mM) after which the plates were further
incubated for 3 h. The contents were then replaced with
equal amounts of DMSO to solubilise the formazan grains
formed by viable cells. Finally, the absorbance was read at
570 nm using a multi-well plate reader (Thermo, Multiskan
spectrum). The viability percentage was calculated by using
the formula below:
Viability % ¼ Absorbance of test sample
 100=Absorbance of solvent control:
Fluorescence microscopy
ZR751 cells (2 × 104 cells/well) were cultured in 96-well
culture plates, treated with or without test samples and
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intercalate fluorescent dyes EB and AO [16], and analyzed
under a fluorescence microscope (Nikon, TS 100-F).
DNA fragmentation assay
For laddering experiments, ZR751 cells (2 × 105 cells/well)
were cultured in 6-well culture plates, treated with or
without test samples and incubated for 24 h. Cells were
then harvested, washed with ice-cold PBS (pH 7.2), and
centrifuged at 500 g for 6 min at 4°C. The resulting cell
pellet was dispersed in 30 μl of lysis buffer (10 mM EDTA;
50 mM Tris HCl, pH 7.8; 1% SDS) by gentle vortexing.
4 μl of proteinase-K (10 μg/μl) was then added to the
above mixture, followed by incubation at 37°C for 1 h.
Then, 2 μl of RNase (10 μg/μl) was added to the cell ly-
sates, which were further incubated for 1 h at 57°C. After
incubation cell lysates were mixed with 4 μl of 6X DNA
loading dye and subjected to run at 2% agarose gel elec-
trophoresis. The gel was then stained with ethidium
bromide (0.5 μg/ml) and visualized under a gel documen-
tation system (Bio-Rad).
Flow cytometry
Cell cycle analysis was carried out using PI staining [17].
ZR751 cells (2 × 105 cells/well) were cultured in 6-well
culture plates, treated with or without test samples for
24 h. After incubation, cells were harvested and fixed in
ice-cold 70% ethanol overnight at −20°C. Fixed cells
were then treated with 0.5 ml of DNA extraction buffer
(192 ml of 0.2 M Na2HPO4 with 8 ml of 0.1% Triton X-100
(v/v)) for 5 min at room temperature. DNA was stained
with PI (0.02 mM) and incubated for 1 h in the dark. Flow
cytometric analysis was then performed using a flow
cytometer (BD FACSCaliber).
Assessment of caspase activities
Caspase-3/7, caspase-8 and caspase-9 activity was assayed
by measuring the light intensity using an assay kit (Cas-
pase-Glo® 3/7Assay, Caspase-Glo® 8 Assay and Caspase-
Glo® 9 Assay, Promega) with some modification. Briefly,
ZR751 cells (1 × 105 cells/well) were treated with different
concentrations (5–40 μg/ml) of test samples for 24 h.
After incubation, cell pellets were lysed in lysis buffer
(50 mM Tris–HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.1%
SDS, 2 mM EDTA, 1 mM phenylmethylsulfonylfluoride
and protease inhibitor cocktail). Equal amount of protein
extract cell lysates were loaded in opaque white 96-well
plates and 40 μl of caspase-3/7 or caspase-8 or caspase-9
reaction buffer was added and incubated at room
temperature for 1 h before measurement.
RNA extraction and reverse transcriptase PCR
The ZR751 cells (2 × 105 cells/well) were cultured in 6-
well culture plates, treated with or without test samplesfor 24 h. After incubation, total RNA was prepared using
an RNeasy kit (Qiagen) and primed with random hexam-
ers to synthesize complementary DNA using superscript
II reverse transcriptase (Invitrogen) according to the man-
ufacturer’s instructions. Polymerase chain reaction (PCR)
was carried out in a Mastercycler (Biorad) with specific
primers (Additional file 1: Table S1). Amplification prod-
ucts obtained by PCR were electrophoretically separated
on 1.5% agarose gel, stained with ethidium bromide
(0.5 μg/ml) and visualized under gel documentation system
(Bio-Rad).
Western blot analysis
Protein expression was carried out as per the standard
protocol [18]. Briefly, ZR751 cells (2 × 105 cells/well)
were cultured in 6-well culture plates, treated with dif-
ferent concentrations (5–40 μg/ml) of PE extract for
24 h. Cell pellets were lysed in lysis buffer (50 mM Tris–
HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.1% SDS, 2 mM
EDTA, 1 mM phenylmethylsulfonylfluoride and protease
inhibitor cocktail). Equal amount of protein extract cell
lysates were electrophoresed in SDS polyacrylamide gel
and then transferred onto PVDF membranes. The mem-
branes were subsequently incubated with primary anti-
bodies of anti-p53, anti-BAX, anti-Bcl2, anti-caspase-3,
anti-PARP, anti-cleaved PARP or anti-β-actin at room
temperature for 60 min. Antibody recognition was detected
with the anti-rabbit or anti-mouse IgG linked to horserad-
ish peroxidase at room temperature for 60 min. Protein
bands were visualized on Chemi Doc XRS Imaging System,
Bio-Rad after treating with enhanced chemiluminescence
reagent.
siRNA interference
p53 expression was knocked down using validated si-
lencer TP53 siRNA (Ambion). Sequences were: sense
5′-GUAAUCUCAUGGGACGGAAtt-3′ and antisense
5′- UUCCGUCCCAGUAGAUUACca-3′. For siRNA
transfection experiments, ZR751 cells were plated and
transfected after 24 h at ~70% confluency by using
Lipofectactamine RNAiMAX transfection agent, accord-
ing to the manufacturer's instructions. After 24 h of trans-
fection, cells were exposed to different concentrations of
PE extract for 24 h prior to analysis of protein expression
by western blot or cell viability by MTT assay. A non-
targeting control siRNA (SilencerH Negative Control-
Ambion) was used as transfection control.
Thin layer chromatography
Equal concentration (16 μg/μl) of CGN extracts were
loaded on silica gel 60 TLC aluminium sheets. The plates
were developed using petroleum ether: ethyl acetate (5:2).
The spots were located by exposing the plates to UV light
(365 nm).
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The values are presented as mean ± SD (standard
deviation). Comparision between two groups were
done by t–test and multiple comparisons between
more than two groups were performed by one-way
ANOVA supplemented with Tukey’s HSD test. Values
at P < 0.05 were considered to indicate statistical
significance.
Results
CGN extracts treatment induces death of human cancer
cells
Effects of the three CGN extracts in six graded doses on
three tumor cell lines (HeLa, HepG2 and ZR751) are
shown in Figure 1. All the extracts induced death of tested
cancer cells. The relative number of surviving cells de-
creased in a dose-dependent manner and the magnitude of
effects varied depending on the cancer cells tested. Among
the extracts, PE extract exhibited the maximum antiprolif-
erative effect in all the cancer cells tested followed by ACE
and MeOH extract (P < 0.01-0.001). PE extract induced
maximum cell death in ZR751 cells (P < 0.001) (Figure 1;
Table 1) indicating the selective cytotoxicity of PE extract
towards breast cancer cells.
CGN PE extract treatment induces apoptosis of human
breast cancer cells
Morphological changes of ZR751 cells caused by PE extract
were analyzed using fluorescence microscope (Figure 2A)
after staining the cells with AO/EB. The untreated ZR751
cells showed no contact inhibition with large nucleus. PE
extract incubation led to dramatic alterations of theFigure 1 CGN extract treatment reduces human cancer cell viability. (
from 5 – 160 μg/ml for up to 24 h prior to analysis of cell viability by MTT
from three independent experiments. Accordingly, IC50 were also determin
different letters, within each row, are significantly different (P < 0.05) analysnormal cellular architecture of ZR751 cells, and showed
characteristic features of apoptosis. These included con-
tact inhibition, nuclear contraction and nuclear fragmen-
tation. Correspondingly, nucleosomal DNA fragmentation
of ZR751 cells was also clearly visible due to the treatment
with PE extract (Figure 2B).
CGN PE extract treatment induces cell cycle arrest in
human breast cancer cells
The effect of PE extract on cell cycle distribution in
ZR751 cells are shown in Figure 3. Treatment of ZR751
cells with PE extract resulted in significant increase of G2
phase cells compared to the control (P < 0.001). The accu-
mulation of cells in G2 increased in a dose dependent
manner. This increase was coupled with the decreased
percentage of cells in S and G1 phase (P < 0.001) except in
5 μg/ml treatment. Further, the sub-G0/G1 population, a
biochemical marker of apoptosis [19] was significantly
higher in the PE extract treated cells than the untreated
control (P < 0.001). The increase in sub-G0/G1 population
was concentration dependent. A statistically significant
positive correlation was observed between the G2 and
sub-G0/G1 cell accumulation (r = 0.905; P < 0.01). Overall,
these results indicate that PE extract induced ZR751 cell
death may be due to the induction of G2 cell cycle arrest
and subsequent apoptotic process.
CGN PE extract treatment activates both intrinsic and
extrinsic pathways in human breast cancer cells
Treatment with PE extract up-regulated p53 and BAX ex-
pression and down-regulated Bcl2 expression in ZR751
cells (Figure 4A). Further, incubation of ZR751 cells withA) HeLa (B) HepG2 and (C) ZR751 cells were treated with doses range
assay. Cell survival was determined as the percentage of the control
ed. Each bar represents the mean ± SD (n = 3). Means marked with
ed by one-way ANOVA supplemented with Tukey’s HSD test.
Table 1 IC50 values of Cephalotaxus griffithii needle





HeLa 83.5 ± 7.2p 143 ± 10.2q 205.2 ± 16.2r
HepG2 66.3 ± 6.1p 128.9 ± 13.1q 275.3 ± 19.1r
ZR751 22.3 ± 3.9p 151.4 ± 13.8q 343 ± 16.2r
Means marked with different letters, within each row, are significantly different
(P < 0.05) analysed by one-way ANOVA supplemented with Tukey’s HSD test.
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level (P < 0.05) of caspase-3 (Figure 4A and 4B). Corres-
pondingly, the activity of caspase-3 was also significantly
increased (P < 0.001). A significant increase was observed
even at the lowest test concentration (5 μg/ml). However,
no significant dose dependent activity of caspase-3 was ob-
served among the treated concentrations (Figure 4B). The
presence of activated caspase-3 was also confirmed based
on the degradation of PARP (a DNA repair enzyme), into
its characteristic 89 kDa fragment, produced as a result of
cleavage by caspase-3 during apoptosis (Figure 4A). Treat-
ment of ZR751 cells with PE extract also resulted in the in-
creased activity of caspase-8 and −9, initiator caspases,
upstream activators of caspase-3/7, suggesting the involve-
ment of both extrinsic and intrinsic apoptotic pathways.
The activity of both caspase-8 and caspase-9 were in-
creased in a dose dependent manner (Figure 4B).Figure 2 CGN PE extract treatment induces apoptosis in human brea
or without PE extract for 24 h prior to stain with AO/EB and viewed under fluo
features of apoptosis such as nuclear condensation (white arrow) and nuclear
20 μg/ml) or without PE extracts for 24 h prior to DNA fragmentation assay. Th
positive control (curcumin), 5 μg/ml PE extract, 10 μg/ml PE extract, 20 μg/ml Pp53 is essential for loss of cell viability induced by CGN
PE extract in human breast cancer cells
The effect of p53 expression on antiproliferative activity of
PE extract is shown in Figure 5 Silencing p53 expression
resulted in significant change in the growth inhibition of
PE extract on ZR751 cells. Comparing to cells with normal
p53 expression, the antiproliferative activity was signifi-
cantly lower in cells with silenced p53 gene (Figure 5).CGN PE extract treatment down-regulates hTERT, hTR and
c-Myc expression in human breast cancer cells
PE extract treatment decreased hTERT and hTR mRNA
levels in a concentration dependent manner but had no
effect on TEP-1 expressions (Figure 6) of ZR751 cells. A
significant down-regulation of hTERT and hTR levels
were observed due to treatment of cells at 20 μg/ml and
40 μg/ml concentrations relative to that in untreated
cells. Application of PE extract also significantly down-
regulated c-Myc expression in a dose-dependent manner
with a significant reduction of c-Myc expression seen in
the last two highest concentrations (Figure 6).CGN PE extract contains unique phytochemicals
TLC profile of CGN extracts is shown in Figure 7. The
chromatogram pattern of PE extract was distinctly dif-
ferent as compared with the other two extracts. Three
spots settled at the Rf value 0.78, 0.71 and 0.61 observed
in PE extract were not visible in case of ACE and MeOHst cancer cells. (A) ZR751 cells were treated with (5, 10 and 20 μg/ml)
rescence microscope (400×). The treated ZR751 cells showed characteristic
fragmentation (blue arrow). (B) ZR751 cells were treated with (5, 10 and
e lane NC, PC, 5, 10, 20 and M represent treatment with negative control,
E extract, and marker (1 kb DNA ladder), respectively.
Figure 3 CGN PE extract induces cell cycle arrest in human breast cancer cells. ZR751 cells were treated with (5, 10 and 20 μg/ml) or without
PE extract for 24 h prior to cell cycle analysis. Each bar represents the mean ± SD (n = 3). Data denoted ***(P< 0.001) are significant compared to controls,
as analysed by t-test.
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0.49, 0.32 and 0.16, although the intensity of the spots
was much higher in PE extract.
Discussion
This is the first report on the effect of CGN on human
malignant tumor cells. For this study, the CGN was suc-
cessively extracted with PE, ACE and MeOH. The anti-
proliferative activity was performed using MTT reduction
assay on three different cancer cell lines (HeLa, HepG2
and ZR751 cells) to check the efficacy of the extracts in re-
ducing the survival rate of the cancer cells. Irrespective ofFigure 4 CGN PE extract treatment causes caspase dependent apopto
treated with (5 – 40 μg/ml) or without PE extract for up to 24 h. Protein ex
termined by western blot. β - actin was used as loading control (B) ZR751
24 h prior to caspase-3, caspase-8 and caspase-9 activity assay. Each bar rep
within each caspase activity are significantly different (P < 0.05) analysed bythe extracts, the antiproliferative activity was found to be
concentration dependent. It was also observed that the an-
tiproliferative activity of the extracts were different and
specific towards the cell type. Overall, PE extract induced
the maximum cancer cell death followed by in ACE and
MeOH extract. PE extract showed the highest growth in-
hibition towards ZR751 cells followed by HepG2 and
HeLa cells. Our earlier study on C. griffithii bark extracts,
observed that PE extract showed the least growth inhibi-
tory effect [11] on HeLa cells. In that study, the highest
antiproliferative activity was found in ACE extract treat-
ment. This suggests that the cytotoxic componentstic cell death in human breast cancer cells. (A) ZR751 cells were
pression of p53, BAX, Bcl2, caspase-3, PARP and cleaved-PARP was de-
cells were treated with (5 – 40 μg/ml) or without PE extract for up to
resents the mean ± SD (n = 3). Bars marked without a common letter
one-way ANOVA supplemented with Tukey’s HSD test.
Figure 5 CGN PE extract induced cellular death is dependent on p53 expression in human breast cancer cells. ZR751 cells were
transfected with TP53 siRNA for 24 h. After transfection, cells were exposed to different concentrations of PE extract for 24 h prior to analysis
of (A) p53 expression by western blot or (B) cell viability by MTT assay. Each bar represents the mean ± SD (n = 3). Data denoted *(P< 0.05), **(P< 0.01),
***(P< 0.001) and ****(P< 0.0001) are significantly different compared to PE extract treatment alone (without TP53 siRNA treatment) between the same
treatment concentration analysed by t-test.
Figure 6 CGN PE extract reduces hTERT, hTR and c-Myc expression in human breast cancer cells. ZR751 cells were treated with (5 – 40 μg/ml)
or without CGN PE extract for up to 24 h. mRNA expression of hTERT, TEP1, hTR and c-Myc was determined by reverse transcriptase PCR. GAPDH was
used as loading control. Each bar represents the mean ± SD (n = 3). Data denoted *(P < 0.05), **(P < 0.01) and ***(P < 0.001) are significant compared to
control analysed by one-way ANOVA supplemented with Tukey’s HSD test.
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Figure 7 CGN PE extract contains unique phytochemicals. Thin
layer chromatographic pattern of different CGN extracts (PE, ACE and
MeOH) exposed to UV 356 nm with Rf values.
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ically different.
Since, PE extract induced cell death was highest among
the CGN extracts, with maximum cancer cell death oc-
curred in ZR751 cells; we carried out mechanism study of
PE extract induced ZR751 cell death. Generally, anticancer
agents have been reported to induce cell death by blocking
cell cycle progression and triggering tumor cell apoptosis
[20-22]. Therefore, cell cycle arrest and the induction of
apoptosis in cancer cells become the major indicators of
anticancer effects. To ascertain whether PE extract induced
cytotoxicity on ZR751 cells was mediated through apop-
tosis and cell cycle arrest; morphological, biochemical,
and cell cycle analysis were carried out. In the morpho-
logical study, most of the ZR751 cells showed character-
istic features of apoptosis such as nuclear contraction,
nuclear fragmentation and contact inhibition due to
treatment with PE extract. Biochemically, apoptosis is
characterized by activation of endogenous nucleases
and fragmentation of DNA [23] which we observed inthe DNA fragmentation assay on ZR751 cells after treat-
ment with PE extract. Moreover, these fragmented nu-
cleosomal DNA bands were very conspicuous as the
concentration of PE extract increased. Further, cell cycle
analysis of treated ZR751 cells with PE extract caused
cell cycle arrest at G2 phase (P < 0.001). Furthermore,
the sub-G0/G1 population, a biochemical marker of
apoptosis [24] with hypo-diploid DNA, was significantly
higher in PE extract treated cells as compared to un-
treated control. A positive correlation was observed
between the G2 cell built up and sub-G0/G1 cell accu-
mulation suggesting that the cause of ZR751 cell death
by PE extract may be due to the induction of G2 cell
cycle arrest and subsequent apoptotic process.
The p53 protein is an essential molecule that arrests
cells with damaged DNA in G2, allowing time for DNA
repair before the cell tries to enter the M phase. But if
the cell is committed to division or the damage cannot
be repaired, then p53 triggers a program cell death through
the extrinsic and intrinsic apoptotic pathways [25,26]. In
this study, treatment of PE extract on ZR751 cells, which
express a functional wild-type p53 protein [27] caused a
significant increased of p53 protein expression. Further, we
observed that p53 expression has a direct impact on the
antiproliferative activity of ZR751 cells. When the p53 gene
expression was knockdown, there was a significant reduc-
tion in the cell death induced by PE extract. This suggests
that p53 is an essential target for PE extract of CGN.
Among the genes activated by p53 is the pro-apoptotic
protein Bax, a key member of the Bcl2 family proteins [28],
and the importance of the Bax to drug-induced apop-
tosis is becoming increasingly apparent [29]. Bax forms
a homodimer and releases cytochrome c from the
mitochondria, which results in caspase-9 activation.
Treatment with PE extract on ZR751 cells caused an
increase in the expression of Bax which was inversely
mirrored by a decrease in Bcl2 expression, an anti-
apoptotic regulator. The increase in Bax expression are
strongly indicative of increased p53 function whether
by increased expression or activity as Bax expression
can also be regulated by p53 [30].
The effector proteins in the apoptotic pathway are en-
zymes called caspases are a family of cysteine proteases that
cleave target sites at aspartate residues, constitute key com-
ponents of the apoptotic pathway. Caspase-9 triggered
mitochondria pathway and the caspase-8 mediated death
receptor-mediated pathway are two pathways involved in
apoptosis. The caspase −9 and −8 are upstream caspases
that converge to caspase-3 [26], a key effector molecule in
the caspase-dependent cell apoptosis pathway that cleaves
a number of cellular proteins including PARP, leading to
DNA fragmentation and triggering apoptosis [31]. In this
study, treatments with PE extract on ZR751 cells up-
regulated the expression of caspase −8, caspase-9 and
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PE extract induced apoptosis via the activation of both
caspase-dependent pathway through caspase-9 triggered
mitochondria pathway and caspase-8 mediated death re-
ceptor pathway.
It has been reported that resistance to apoptosis is
associated with telomerase expression in human can-
cer cells [32]. Telomeres are essential units that pre-
vent the loss of genetic information. In normal somatic
cells, which show little or no telomerase activity in synthe-
sizing new telomeres at the ends of replicating chromo-
somes, the telomeric DNA progressively shortens with
each cell division. Extensive shortening of telomeres is
detected as a kind of DNA damage; as a result p53 is
activated, leading to p53-triggered apoptosis. Most
tumor cells, despite their rapid proliferation rate, stabilises
by expressing telomerase [33]. It has been reported that
telomerase has anti-apoptotic role and up-regulation of
telomerase helps cancer cells to resist against therapeutic
drug-mediated cell death. Since, telomerase is essential for
a tumor cell to become immortal, and specific inhibitors
of telomerase have been suggested as a new strategy for
cancer therapy [34-36]. Telomere length in humans is pri-
marily controlled by three major components, hTERT,
TEP-1, and hTR. It has been shown that hTERT mRNA
expression correlates with telomerase activity in human
breast cancer cells [37]. In this study, we observed that
application of PE extract on ZR751 cells down-
regulated the expression of hTERT and hTR. These
suggest that suppression of telomerase may also be one
of the causes for ZR751 cell death upon treatment with
PE extract of CGN. Expression of hTERT is strictly
regulated at the transcriptional level by several tran-
scription factors, particularly, c-Myc [38]. Correspond-
ingly, with the hTERT down-regulation, the expression
level of c-Myc in ZR751 cells was down-regulated after
PE extract treatment.
TLC analysis revealed the presence of unique phyto-
chemicals in the PE extract suggesting that the differences
and concentration of phytochemicals in the PE extract was
responsible for producing the maximum antiproliferative
effect on the cancer cells.
Conclusion
Based on our results, we concluded that CGN contain
bioactive components responsible for inducing antiproli-
feration, cell cycle arrest, apoptosis and telomerase sup-
pression. Among the extracts, PE extract exhibited the
highest cytotoxic effect on cancer cells. PE extract induced
death of ZR751 cells by acting to multiple targets viz. cell
cycle arrest, apoptosis and suppression of telomerase.
These results call for further chemical characterization of
PE extract of C. griffithii needle for isolation of active anti-
neoplastic principle.Additional file
Additional file 1: Table S1. Details of the primers used for the
amplification.
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